Literature DB >> 17110010

Prolactin and estradiol serum levels in unmedicated male paranoid schizophrenia patients.

Michael Segal1, Avi Avital, Severina Berstein, Andrei Derevenski, Sergio Sandbank, Abraham Weizman.   

Abstract

There is evidence for the involvement of the endocrine system in schizophrenia. This involment was widely investigated in female patients. In the current study, we examined prolactin and estradiol serum levels in hospitalized unmedicated men with first-episode and recurrent schizophrenia and then tested possible correlation with various subtypes of the disease. In addition, the estradiol and prolactin levels were compared with a healthy control group. The serum samples were assessed the morning following admission in fifty-seven schizophrenia male patients. There was a significant difference in prolactin serum levels between the paranoid and "nonparanoid" schizophrenia subgroups. However, no significant differences were found in estradiol serum levels between schizophrenia subtypes or between the patients and their healthy counterparts. Finally, a significant and positive correlation was found between the prolactin and estradiol levels in the paranoid subgroup alone. Thus, it appears that low estradiol levels are associated with low prolactin levels, alleged hyperdopaminergic tone and psychotic breakdown in paranoid schizophrenia. The results of the present study further support our previous report of the association between prolactin serum levels and the schizophrenia cluster subtypes, indicating a different dopaminergic activity for the various forms of the disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17110010     DOI: 10.1016/j.pnpbp.2006.09.016

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  10 in total

1.  Prolactin concentrations in newly diagnosed, antipsychotic-naïve patients with nonaffective psychosis.

Authors:  Clemente Garcia-Rizo; Emilio Fernandez-Egea; Cristina Oliveira; Azucena Justicia; Eduard Parellada; Miguel Bernardo; Brian Kirkpatrick
Journal:  Schizophr Res       Date:  2011-08-09       Impact factor: 4.939

2.  Plasma prolactin is higher in major depressive disorder and females, and associated with anxiety, hostility, somatization, psychotic symptoms and heart rate.

Authors:  Asmahan Elgellaie; Theresa Larkin; Jacqueline Kaelle; Jessica Mills; Susan Thomas
Journal:  Compr Psychoneuroendocrinol       Date:  2021-03-20

Review 3.  Toward defining schizophrenia as a more useful clinical concept.

Authors:  Jess G Fiedorowicz; Eric A Epping; Michael Flaum
Journal:  Curr Psychiatry Rep       Date:  2008-08       Impact factor: 5.285

4.  Impact of Bisphenol A on Gonadotropic Hormone Levels in Children with Autism Spectrum Disorders.

Authors:  Fateheya M Metwally; Hend Rashad; Hala M Zeidan; Adel F Hashish
Journal:  Indian J Clin Biochem       Date:  2018-12-10

Review 5.  The effects of novel and newly approved antipsychotics on serum prolactin levels: a comprehensive review.

Authors:  J Peuskens; L Pani; J Detraux; M De Hert
Journal:  CNS Drugs       Date:  2014-05       Impact factor: 5.749

6.  Hyperprolactinemia and insulin resistance in drug naive patients with early onset first episode psychosis.

Authors:  Maria Giuseppina Petruzzelli; Mariella Margari; Antonia Peschechera; Concetta de Giambattista; Andrea De Giacomo; Emilia Matera; Francesco Margari
Journal:  BMC Psychiatry       Date:  2018-08-01       Impact factor: 3.630

7.  Abnormally low prolactin levels in schizophrenia patients after switching to aripiprazole in a randomized trial: a biomarker for rebound in psychotic symptoms?

Authors:  Ya-Wen Jen; Tzung-Jeng Hwang; Hung-Yu Chan; Ming H Hsieh; Chen-Chung Liu; Chih-Min Liu; Hai-Gwo Hwu; Ching-Hua Kuo; Yi-Ting Lin; Yi-Ling Chien; Wei J Chen
Journal:  BMC Psychiatry       Date:  2020-11-23       Impact factor: 3.630

Review 8.  Effects of bisphenol-A and other endocrine disruptors compared with abnormalities of schizophrenia: an endocrine-disruption theory of schizophrenia.

Authors:  James S Brown
Journal:  Schizophr Bull       Date:  2008-01-31       Impact factor: 9.306

Review 9.  Prolactin and psychopathology in schizophrenia: a literature review and reappraisal.

Authors:  Ravi Philip Rajkumar
Journal:  Schizophr Res Treatment       Date:  2014-03-27

Review 10.  An Emerging Role of micro-RNA in the Effect of the Endocrine Disruptors.

Authors:  Adel Derghal; Mehdi Djelloul; Jérôme Trouslard; Lourdes Mounien
Journal:  Front Neurosci       Date:  2016-06-30       Impact factor: 4.677

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.